Position in FATE
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$972,000
+$158,600 QoQ
Shares Held
810,000
-2.4% QoQ
Ownership
0.695%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FATE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Monaco Asset Management SAM holds $38,256,689 across 13 Biotechnology names. FATE ranks #8 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
3,421,020 | $9,681,486 | |
| 2 | RCKT |
Rocket Pharmaceuticals, Inc.
|
2,058,303 | $7,368,724 | |
| 3 | NVAX |
Novavax Inc
|
697,600 | $5,678,464 | |
| 4 | NKTX |
Nkarta, Inc.
|
2,521,932 | $5,321,276 | |
| 5 | PLRX |
Pliant Therapeutics, Inc.
|
1,938,747 | $2,442,821 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
30,000 | $1,694,700 | |
| 7 | VNDA |
Vanda Pharmaceuticals Inc.
|
241,286 | $1,667,286 | |
| 8 | FATE |
Fate Therapeutics Inc
This page
|
810,000 | $972,000 |
All Filings in FATE
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $972,000 | 810,000 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $813,400 | 830,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $970,200 | 770,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $756,000 | 675,000 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $908,269 | 1,149,708 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $540,657 | 327,671 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $481,848 | 137,671 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $941,032 | 286,900 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,325,348 | 316,805 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $8,165,272 | 2,183,228 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,917,641 | 1,847,944 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $4,784,875 | 1,005,226 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $5,530,670 | 970,293 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,522,500 | 250,000 | Shares | Sole | 2023-02-03 | |
| No filing history on record for this holder in this stock. | ||||||